Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS15AP15 is a processed pseudogene derived from the ribosomal protein S15a gene. Pseudogenes are typically nonfunctional genomic sequences that resemble functional genes but do not encode proteins. While the parent gene (RPS15A) is a structural component of the ribosome implicated in several critical cellular tasks, RPS15AP15 itself is not expressed as a protein and does not fulfill a drug-target role. There is no evidence in available scientific databases or literature of RPS15AP15 being involved in disease, biological pathways, or drug interactions. If your interest is in functional ribosomal proteins, refer to RPS15A (Ribosomal protein S15a). RPS15AP15 is not a canonical therapeutic target; it is a pseudogene, and selecting it as a drug target would be incorrect unless new research shows otherwise. The parent protein-coding gene, RPS15A, is the functional component relevant in ribosome biology.
None applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S15a pseudogene 15 (RPS15AP15).